New York State Common Retirement Fund
SYRS

New York State Common Retirement Fund’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

New York State Common Retirement Fund’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-62
Closed -$1K – 3482
2022
Q2 		$1K Sell
62
-3,360
-98% -$31.4K ﹤0.01% 3430
2022
Q1 		$41K Buy
3,422
+14
+0.4% +$250 ﹤0.01% 3206
2021
Q4 		$111K Sell
3,408
-20
-0.6% -$810 ﹤0.01% 3047
2021
Q3 		$153K Buy
3,428
+27
+0.8% +$1.32K ﹤0.01% 3005
2021
Q2 		$185K Buy
3,401
+41
+1% +$2.43K ﹤0.01% 3074
2021
Q1 		$251K Buy
3,360
+450
+15% +$46.8K ﹤0.01% 2743
2020
Q4 		$316K Sell
2,910
-1,130
-28% -$103K ﹤0.01% 2570
2020
Q3 		$357K Hold
4,040
– – ﹤0.01% 2376
2020
Q2 		$431K Buy
4,040
+910
+29% +$81.7K ﹤0.01% 2295
2020
Q1 		$186K Buy
3,130
+20
+0.6% +$1.36K ﹤0.01% 2498
2019
Q4 		$215K Sell
3,110
-420
-12% -$25.5K ﹤0.01% 2712
2019
Q3 		$366K Hold
3,530
– – ﹤0.01% 2486
2019
Q2 		$327K Buy
3,530
+820
+30% +$57.1K ﹤0.01% 2580
2019
Q1 		$248K Hold
2,710
– – ﹤0.01% 2624
2018
Q4 		$151K Hold
2,710
– – ﹤0.01% 2827
2018
Q3 		$323K Hold
2,710
– – ﹤0.01% 2613
2018
Q2 		$277K Buy
2,710
+1,370
+102% +$170K ﹤0.01% 2729
2018
Q1 		$174K Hold
1,340
– – ﹤0.01% 2791
2017
Q4 		$130K Hold
1,340
– – ﹤0.01% 2920
2017
Q3 		$197K Hold
1,340
– – ﹤0.01% 2778
2017
Q2 		$216K Buy
1,340
+840
+168% +$132K ﹤0.01% 2809
2017
Q1 		$80K Hold
500
– – ﹤0.01% 3004
2016
Q4 		$61K Buy
+500
New +$70.1K ﹤0.01% 3037

Other funds holding SYRS

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

New York State Common Retirement Fund's SYRS Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q3 2022, closing a stake of 62 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in SYRS in Q4 2016 and held it in 23 quarters. The position peaked at $431K in Q2 2020. 53 funds tracked by Wall St. Rank hold SYRS as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 62 Syros Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $1K.
  • New York State Common Retirement Fund first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2016 and held it in 23 quarters.
  • New York State Common Retirement Fund's Syros Pharmaceuticals, Inc. Common Stock position peaked at $431K in Q2 2020.
  • 53 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.